Feb. 15, 2013, 11:58 AMIGI Laboratories (IG +2.2%) trades up after signing a three-year agreement with Juventio LLC to manufacture and supply finished dose forms of certain cosmetic and OTC products and formulations owned and developed by IGI. The products utilize encapsulation technology trademarked as Novasome for which the company currently holds an exclusive license. | Feb. 15, 2013, 11:58 AM | Comment!
IGI vs. ETF Alternatives
As a fundamental policy, the Fund seeks to achieve its primary investment objective by investing, under normal market conditions, at least 80% of its net assets in investment grade corporate fixed income securities. In addition, the Fund may invest up to 2
Other News & PR